FluroTech Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FLURF research report →
About the company
FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry. The company is responsible for developing the FluroTest SARS-CoV-2 diagnostic, which is designed to pinpoint patients with active viral infections.
- CEO
- Michael Rodyniuk
- IPO
- 2019
- HQ
- Calgary, AB, CA
Price Chart
- Market Cap
- $447.18K
- P/E
- -2.37
- P/S
- 0.00
- P/B
- -1.43
- EV/EBITDA
- 171.02
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 80.08%
- ROIC
- 299.44%
- Revenue
- $0 · 0.00%
- Net Income
- $-107,000 · 90.47%
- EPS
- $-0.00 · 91.00%
- Op Income
- $-144,000
- FCF YoY
- 23.99%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.44
- Avg Volume
- 0
Get TickerSpark's AI analysis on FLURF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FLURF coverage
Recent articles, reports, and earnings notes.
No research on FLURF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FLURF report →Similar companies
Peers in the same neighborhood.